Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine added to palonosetron + dexamethasone for prevention of cisplatin-induced nausea and vomiting during 3-day chemotherapy
ChiCTR-IPR-14005265Phase 3Recruiting
- Sponsor
- The Fourth Hospital of China Medical University
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of olanzapine, palonosetron and dexamethasone in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by The Fourth Hospital of China Medical University. Primary endpoints: Complete response of overall phase and Safety and effectiveness of olanzapine. Started Nov 2014; status: recruiting.
02
Drugs
olanzapinepalonosetrondexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR-IPR-14005265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005265.